通过生物信息学分析识别的SYK促进了多发性骨髓瘤的扩散
Ju Deng1,2,3, Peichun Li1,2,3, Shuo Li1,2,3
1Institute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Expert review of hematology
|May 19, 2025
概括
腺氨酸激酶 (SYK) 是多发性骨髓瘤 (MM) 的一个有前途的治疗点. 在临床前模型中,用BAY61-3606抑制SYK有效降低了MM细胞活力和瘤生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 多发性骨髓瘤 (MM) 的发病因子尚未完全理解,复发/耐药性需要新的治疗点.
- 识别新的分子标对于改善MM治疗结果至关重要.
研究的目的:
- 确定和验证多发性骨髓瘤 (MM) 的新型治疗点.
- 研究腺氨酸激酶 (SYK) 在MM进展中的作用及其作为治疗点的潜力.
主要方法:
- 对基因表达数据集 (GSE6477,GSE6691) 的生物信息分析,以确定候选基因.
- 功能性注释,路径丰富和蛋白质-蛋白质相互作用网络的构建.
- 使用ex vivo测定和in vivo异种移植模型验证候选基因.
主要成果:
- 腺氨酸激酶 (SYK) 被确定为MM的显著预后基因 (p=0.027).
- 通过BAY61-3606抑制SYK降低了MM细胞活力,诱导细胞循环停止,并促进了细胞亡.
- 在MM异种移植模型中,BAY61-3606显著抑制了瘤生长.
结论:
- 腺氨酸激酶 (SYK) 是多发性骨髓瘤 (MM) 的验证治疗点.
- 针对SYK提供了开发新型MM治疗的潜在策略.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.7K
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
